Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05551702
Other study ID # Dep 2.0
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 6, 2022
Est. completion date December 2024

Study information

Verified date May 2024
Source The University of Tennessee, Knoxville
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the research study is to investigate whether CBT-txt, a counseling program delivered by text messages is effective in stopping or reducing depressive symptoms. CBT-txt is based on a counseling program that has been proven to reduce depression when delivered in-person and on the web, but has not yet been tested or shown to be effective when delivered by text.


Description:

After being informed about the study and potential risks, participants will complete online screening assessments. Once eligibility is confirmed, participants will be randomized either to the intervention group or to the waitlist-control group. Those who are randomized to the intervention group will receive the 8-week text intervention via smartphone and complete assessments at baseline, 1 month, 2 months, and 3 months. Those who are randomized to the waitlist-control group will only complete the assessments at baseline, 1 month, 2 months, and 3 months. Participants who are initially assigned to the waitlist-control group can choose to receive the text intervention once their 3-month participation is complete.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 103
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - 18 to 25 years old - a score of at least 5 on the PHQ-9 (indicating elevated depression symptoms Exclusion Criteria: - treatment for depression during the past three months - endorse suicide ideation on the PHQ-9* - lack of access to a text-capable phone - unable or unwilling to commit to two months of follow-up - not fluent in English.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CBT-txt
Cognitive Behavioral Therapy delivered via automated text messaging.

Locations

Country Name City State
United States University of Tennessee-Knoxville Knoxville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
The University of Tennessee, Knoxville

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Beck Depression Inventory II at 2 Months A 21-item instrument for measuring the severity of depression in adults and adolescents aged 13 years and older. Minimum score =0, Maximum=63. Higher scores indicate more depression. Baseline, 1 Month, 2 Month, 3 Month
Primary Change from Baseline Beck Depression Inventory II at 3 Months A 21-item instrument for measuring the severity of depression in adults and adolescents aged 13 years and older. Minimum score =0, Maximum=63. Higher scores indicate more depression. Baseline, 1 Month, 2 Month, 3 Month
Secondary Change from Baseline Types of Thinking Cognitive Distortion Scale at 2 Months A 10 item scale using scenarios to help recognize cognitive distortions. Minimum score = 20, Maximum = 140. Higher scores equal more cognitive distortions. Baseline, 1 Month, 2 Months, 3 Months
Secondary Change from Baseline Types of Thinking Cognitive Distortion Scale at 3 Months A 10 item scale using scenarios to help recognize cognitive distortions. Minimum score = 20, Maximum = 140. Higher scores equal more cognitive distortions. Baseline, 1 Month, 2 Months, 3 Months
Secondary Change from Baseline Perseverative Thinking Questionnaire at 2 Months A 15 item scale rating statements about negative experiences or problems to identify repetitive negative thinking. Minimum score = 0, Max 60. Higher scores equal more perseverative thinking. Baseline, 1 Month, 2 Months, 3 Months
Secondary Change from Baseline Perseverative Thinking Questionnaire at 3 Months A 15 item scale rating statements about negative experiences or problems to identify repetitive negative thinking. Minimum score = 0, Max 60. Higher scores equal more perseverative thinking. Baseline, 1 Month, 2 Months, 3 Months
Secondary Change from Baseline Behavioral Activation for Depression Scale at 2 Months A 9 items scale to measure how and when participants become activated during behavioral activation treatment. Minimum score = 0, Max = 54. Higher scores equal more behavioral activation. Baseline, 1 Month, 2 Months, 3 Months
Secondary Change from Baseline Behavioral Activation for Depression Scale at 3 Months A 9 items scale to measure how and when participants become activated during behavioral activation treatment. Minimum score = 0, Max = 54. Higher scores equal more behavioral activation. Baseline, 1 Month, 2 Months, 3 Months
See also
  Status Clinical Trial Phase
Completed NCT01977326 - Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South Africa N/A
Completed NCT01635218 - Homeopathic Treatment for Depression in Peri- and Postmenopausal Women Phase 2
Not yet recruiting NCT04766242 - The Impact of Spiritual Healing on Moderate Depression in Adults N/A
Recruiting NCT06005103 - T-PEMF Headband Stimulation for Patients With Moderate to Servere Depression N/A
Recruiting NCT05842278 - The Dosage Effect of pBFS Guided rTMS Treatment for MDD N/A
Not yet recruiting NCT05957341 - pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD N/A
Not yet recruiting NCT06336538 - Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors N/A
Withdrawn NCT05594667 - Effect of SSRIs on Response to Psilocybin Therapy Phase 2
Completed NCT05386745 - Feasibility Study of an Online Physical Activity Intervention for Youth With Depression N/A
Terminated NCT02185547 - Effects and Consequences for Mother and Child From Treatment for Depression Phase 4
Completed NCT03060200 - Reducing Depressive Symptomatology With a Smartphone App N/A
Recruiting NCT06112652 - Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique N/A